United States: FDA Final Rule: IRB Waiver Of Informed Consent For Minimal-Risk Investigations - Jones Day

The Food and Drug Administration expands informed consent exceptions with a final rule permitting institutional review board waiver or alteration of elements for certain FDA-regulated minimal-risk clinical investigations.